ClinConnect ClinConnect Logo
Search / Trial NCT07097961

Paediatric Post-TB Pulmonary Rehab Study

Launched by UNIVERSITY OF IOWA · Jul 30, 2025

Trial Information

Current as of August 28, 2025

Recruiting

Keywords

Post Tb Lung Disease Uganda Pulmonary Rehabilitation Pediatric Tuberculosis

ClinConnect Summary

This study is looking at whether a home-based lung rehabilitation program is possible and acceptable for children aged 6 to 15 who have recently finished treatment for tuberculosis (TB) that affected their lungs. The program lasts six weeks and includes simple exercises like walking and wall sits that children do at home twice a week. The goal is to see if children and their caregivers can follow the program and find it helpful. Researchers will also check if the program helps improve how far children can walk and their overall quality of life.

Children who join the study will first visit a clinic for tests, including a walking test and a questionnaire about their breathing and daily activities. They will then receive instructions, a pedometer to track steps, and weekly support from study staff by phone or in person. After six weeks, they will return for follow-up tests. To be eligible, children must be between 6 and 17 years old, have had lung problems after TB, live in the study area around Kampala, and be able to do mild to moderate exercise. Children currently in other rehab programs or with active lung infections won’t be able to join. This study is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 6-17 years
  • Previously diagnosed with post-TB lung disease,
  • Willing to remain in the study catchment area during the study period
  • Able to participate in mild-to-moderate physical activity (late inclusion criterion)
  • Exclusion Criteria:
  • Currently participating in another rehabilitation program
  • Residence outside the Kampala metropolitan area
  • Active respiratory infection (late exclusion criterion)

About University Of Iowa

The University of Iowa, a leading academic and research institution, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to investigate cutting-edge therapies and treatments across various medical fields. Committed to ethical research practices and patient-centered care, the University of Iowa strives to contribute significantly to medical knowledge and improve health outcomes through rigorous scientific inquiry and community engagement.

Locations

Kampala, , Uganda

Patients applied

0 patients applied

Trial Officials

Greta L Becker, MD

Principal Investigator

University of Iowa

Eric Wobudeya, MBChB, MMED, MSc

Principal Investigator

MU-JHU Care Ltd/MU-JHU Research Collaboration

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported